United Kingdom
Accomplished cell biologist with extensive experience in leading the biology strategy and building data packages for multidisciplinary preclinical drug discovery programmes and translational projects in immuno-inflammation, oncology and neurodegeneration, both in biotech settings and at the interface between academia and industry. Strong interpersonal skills with ability to foster and manage internal and external collaborations within industry and academia. Deep expertise in a wide array of cellular, biochemical and biophysical methodologies for target validation and compound profiling, from hit identification through to preclinical workups.
Lead biologist in cross-functional preclinical drug discovery programmes in immuno-inflammation
Biologist leading cell-based assays development for target validation studies and compound screening in neurodegenerative drug discovery projects
Lead biologist for the Covid19 RdR polymerase project in collaboration with AstraZeneca. Biochemical and cell-based assays development for compound screening and target engagement studies across several target classes for drug discovery projects in oncology in collaboration with UCL group leaders.
Protein Phosphorylation Laboratory - Prof. Peter Parker Led and coordinated a proof-of-concept study in collaboration with AstraZeneca. Team member for early stage drug discovery programmes with Crick-GSK Biomedical LinkLabs and CRUK-Cancer Research Horizons.